Stock GE9 GENMAB A/S
Add to a list
To use this feature you must be a member
Log inSign up

Quotes Genmab A/S Xetra

Equities

GE9

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Tradegate
Other stock markets
 02:17:34 2024-06-10 pm EDT 		5-day change 1st Jan Change
257.8 EUR -22.10% Intraday chart for Genmab A/S 0.00% 0.00%
03:20pm Transcript : Genmab A/S Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-10-2024 09:20 AM
Jun. 04 Truist Securities Raises Price Target on Genmab to $53 From $50, Maintains Buy Rating MT

Performance

1 day-22.10%
3 years+8,260.70%
5 years+8,260.70%
10 years+8,260.70%

Volumes

markets
Daily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
7
Daily volume ratio
0.00
Avg. Volume 20 sessions
1 804.95
Avg. Volume 20 sessions USD
1 941.96
Record volume 1
12 700
Record volume 2
7 348
Record volume 3
6 920
Capital turnover ratio
0.00
Float rotation
0.00

Basic data

Capitalization (EUR)
124 521 796 316
Capitalization (USD)
17 963 265 293
Net sales (DKK)
16 474 000 000
Net sales (USD)
2 376 506 292
Number of employees
2 286
Sales / Employee (DKK)
7 206 474
Sales / Employee (USD)
1 039 592
Free-Float
98.51 %
Free-Float capitalization (EUR)
126 256 604 509
Free-Float capitalization (USD)
18 213 525 253
Average Daily Capital Traded
0%

Highs and lows

3 years
283.00
Extreme 283
353.50
5 years
283.00
Extreme 283
353.50
10 years
283.00
Extreme 283
353.50

Indicators

Moving average 5 days
331.00
Moving average 20 days
331.87
Moving average 50 days
253.59
Moving average 100 days
130.99
Price spread / (MMA5)
+28.37%
Price spread / (MMA20)
+28.71%
Price spread / (MMA50)
-1.65%
Price spread / (MMA100)
-49.20%
RSI 9 days
57.50
RSI 14 days
63.33

Sector Comparison - Bio Therapeutic Drugs

Name Change 5d. change 1st Jan change 1-year change Capi.
GENMAB A/S Stock Genmab A/S
-22.10%0.00%0.00%0.00% 17.96B
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+0.07%+2.92%+18.93%+42.07% 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
-0.25%+1.06%+13.86%+32.63% 108B
BIONTECH SE Stock BioNTech SE
-2.50%-5.13%-7.53%-11.11% 24.21B
ARGENX SE Stock argenx SE
-1.13%+0.92%+2.07%-5.24% 22.78B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-0.45%+0.66%-41.74%-37.14% 16.43B
BEIGENE, LTD. Stock BeiGene, Ltd.
-0.85%+6.02%-14.04%-27.28% 16.37B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
-0.62%-3.91%+2.04%+43.81% 13.58B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
-0.01%-0.87%+27.71%-5.32% 11.66B
INSMED INCORPORATED Stock Insmed Incorporated
+5.03%+5.79%+90.96%+203.49% 9.17B
LEGEND BIOTECH CORPORATION Stock Legend Biotech Corporation
-0.07%+14.04%-24.13%-33.15% 8.31B
ASCENDIS PHARMA A/S Stock Ascendis Pharma A/S
-3.00%-0.90%+6.47%+43.80% 7.87B
VAXCYTE, INC. Stock Vaxcyte, Inc.
+0.08%-1.56%+13.23%+37.04% 7.72B
CEREVEL THERAPEUTICS HOLDINGS, INC. Stock Cerevel Therapeutics Holdings, Inc.
+0.34%-1.30%-5.42%+22.56% 7.29B
HALOZYME THERAPEUTICS, INC. Stock Halozyme Therapeutics, Inc.
+1.09%+14.58%+39.66%+53.27% 6.47B
EXELIXIS, INC. Stock Exelixis, Inc.
+0.57%+0.39%-8.23%+15.32% 6.37B
Average-1.48%+3.10%+7.11%+23.42%
Weighted average by Cap.-1.21%+3.54%+10.05%+26.13%

Historical data

DateOpeningHighLowEnd-of-dayVolume

Chart Genmab A/S

Chart Genmab A/S
More charts

Monthly variations

Annual change

2022-3.50%
2021+8,563.80%
2011-55.77%
2010-20.52%
2009-60.32%
2008-34.38%
2007-12.34%
2006+212.28%
2005+18.71%
2004+107.00%
2003-4.03%
  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. GE9 Stock
  5. Quotes Genmab A/S